GlassScriptPhysician profile
Qian Wang
NPI 1093179194
$342.43
in general payments reported to CMS, 2019-2025
6 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $137 · 2024: $17.09 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $342.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adc Therapeutics America, INC. | $121.24 | 2023-2025 | |
| Tempus Ai, INC | $96.82 | 2025 | Xt Cdx |
| Astrazeneca Pharmaceuticals LP | $60.93 | 2023-2025 | Lynparza, Imfinzi |
| Genmab U.S., INC. | $27.44 | 2025 | Tivdak |
| Janssen Biotech, INC. | $18.91 | 2025 | Rybrevant |
| Array Biopharma INC | $17.09 | 2024 | Mektovi, Braftovi, Xalkori |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Qian Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.